Deproteinised Calf Blood Serum Injection for the Treatment of Acute Intracerebral Hemorrhage
Recruiting
Phase N/A Results N/ASummary of Purpose
The purpose of this study is to investigate the efficacy and safety of Deproteinised Calf Blood Serum Injection in alleviating perihematomal edema (PHE) and secondary brain injury, as well as neurologic deficits in patients with acute intracerebral hemorrhage (ICH).
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 28 August 2017.
1 Jan 2017 | 5 Jan 2017 | 1 Dec 2018 | Unavailable | 1 Aug 2017 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
Not available
Contacts
- Xingquan Zhao, MD
zxq@vip.163.com 8610-67098891
View Trial Locations
Recruitment
- Enrollment: 60
- Gender: All
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country